portfolio > ablativesolutions


Ablative Solutions
founders: david r. fischell, tim fischell
Founded: 2011
Sector: biotechnology, healthcare, medical device
Website: www.ablativesolutions.com
Ablative Solutions, Inc. (“ASI”) has developed and patented a unique product which is a treatment for uncontrolled hypertension. Having successfully completed human trials in Europe, ASI’s plan is to enroll and treat an additional 20-25 patients and to set itself up for a previously approved FDA IND clinic trial. The future trial will include 100 patients with industry leaders as principal investigators at blue-ribbon sites.